02/01/23 6:30 AMNYSE, Nasdaq : BSX, APEN BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022Boston Scientific Corporation generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior year period. The company reported GAAP net income available to common stockholders of $126 million or $0.09 per...RHEA-AIneutral
01/03/23 9:30 AMNYSE : BSX conferencesBoston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2022 ResultsBoston Scientific Corporation (NYSE: BSX) will participate in the 41 st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 in San Francisco, California. Mike Mahoney, chairman and chief executive officer, will present atRHEA-AIneutral
12/11/22 5:17 PMNYSE : BSX acquisitionBoston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings LimitedBoston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, aRHEA-AIvery positive
11/29/22 7:00 AMNasdaq, NYSE : APEN, BSX acquisitionBoston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Apollo Endosurgery,RHEA-AIneutral
11/27/22 12:05 PMNYSE : BSX Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2™ Aortic Valve SystemBoston Scientific Corporation (NYSE:BSX) has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2 TM Aortic Valve System. The findings, which included a highRHEA-AIneutral
11/01/22 9:30 AMNYSE : BSX conferencesBoston Scientific Announces Upcoming Conference ScheduleBoston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.On November 15, 2022, Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, willRHEA-AIneutral
10/26/22 6:30 AMNYSE : BSX Boston Scientific Announces Results for Third Quarter 2022Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.170 billion during the third quarter of 2022, growing 8.1 percent on a reported basis, 13.7 percent on an operational 1 basis and 11.5 percent on an organic 2 basis, all comparedRHEA-AIneutral
10/03/22 9:30 AMNYSE : BSX Boston Scientific Announces Conference Call Discussing Third Quarter 2022 ResultsBoston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2022 on Wednesday, October 26, 2022 at 8:00 a.m. EDT. The call will be hostedRHEA-AIneutral
09/17/22 11:21 AMNYSE : BSX Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL™ Cerebral Protection SystemBoston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINELâ„¢ Cerebral Protection System, which is designedRHEA-AIneutral
09/06/22 6:55 AMNYSE : BSX fda approvalBoston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication OptionBoston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expandRHEA-AIneutral